Evidence map›Paper›PMID 30032975›Full record

ReviewLancet (London, England)2018

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.

Linda-Gail Bekker, George Alleyne, Stefan Baral, Javier Cepeda, Demetre Daskalakis, David Dowdy, Mark Dybul, Serge Eholie, Kene Esom, Geoff Garnett and 37 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Lancet (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 229 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
229citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

229 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. HIV/AIDS in Conflict-Affected Countries, 2024-2025.Journal of epidemiology and global health · 2026
    Article
  20. Article

169 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

47 authors.

Linda-Gail BekkerInternational AIDS Society, Geneva, Switzerland; Desmond Tutu HIV Centre, University of Cape Town, South Africa. Electronic address: Linda-gail.bekker@hiv-research.org.za.
George AlleyneNCD Alliance, Office of the Director, Pan American Health Organization, Washington, DC, USA.
Stefan BaralCentre for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
Javier CepedaDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California-San Diego, San Diego, CA, USA.
Demetre DaskalakisNew York City Department of Health, New York, NY, USA.
David DowdyDepartment of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
Mark DybulCentre for Global Health and Quality, Georgetown University School of Medicine, Washington, DC, USA.
Serge EholieDepartment of Dermatology and Infectious Diseases, Medical School, Felix Houphouet Boigny Universty Abidjan, Cote d'Ivoire.
Kene EsomHIV, Health and Development Group, United Nations Development Programme, New York, NY, USA.
Geoff GarnettHIV Delivery, Bill & Melinda Gates Foundation, Washington, DC, USA.
Anna GrimsrudInternational AIDS Society, Geneva, Switzerland.
James HakimDepartment of Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Diane HavlirDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California-San Francisco, San Fransisco, CA, USA.
Michael T IsbellInternational AIDS Society, Geneva, Switzerland.
Leigh JohnsonSchool of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Adeeba KamarulzamanFaculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Parastu KasaieDepartment of Health, Behaviour and Society, Johns Hopkins University, Baltimore, MD, USA.
Michel KazatchkineUNAIDS and Global Health Center, Graduate Institute, Geneva, Switzerland.
Nduku KilonzoNational AIDS Control Council for Kenya, Nairobi, Kenya.
Michael KlagDepartment of Epidemiology, Johns Hopkins University, Baltimore, MD, USA; Department of Health Policy and Management, Johns Hopkins University, Baltimore, MD, USA.
Marina KleinDivision of Infectious Diseases, Faculty of Medicine, McGill University Health Centre, Montreal, QC, Canada.
Sharon R LewinThe Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Chewe LuoHIV/AIDS Section, United Nations Children's Fund, New York City, NY, USA.
Keletso MakofaneHarvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Natasha K MartinDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California-San Diego, San Diego, CA, USA.
Kenneth MayerThe Fenway Institute, Harvard Medical School, Boston, MA, USA.
Gregorio MillettThe Foundation for AIDS Research, New York City, NY, USA.
Ntobeko NtusiDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Loyce PaceGlobal Health Council, Washington, DC, USA.
Carey PikeDesmond Tutu HIV Centre, University of Cape Town, South Africa.
Peter PiotLondon School of Hygiene and Tropical Medicine, London, UK.
Anton PozniakHIV Services, Chelsea and Westminster NHS Foundation Trust Hospital, London, UK.
Thomas C QuinnCentre for Global Health, Johns Hopkins University, Baltimore, MD, USA; International AIDS Society-National Institute for Drug Abuse, Johns Hopkins University, Baltimore, MD, USA; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, MD, USA.
Jurgen RockstrohHIV Clinic, Department of Medicine, University Hospital Bonn, Bonn, Germany.
Jirair RatevosianDepartment of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
Owen RyanInternational AIDS Society, Geneva, Switzerland.
Serra SippelCenter for Health and Gender Equity, Washington DC, USA.
Bruno SpireAix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.
Agnes SoucatHealth Systems, Governance and Financing, World Health Organisation, Geneva, Switzerland.
Ann StarrsGuttmacher Institute, New York, NY, USA.
Steffanie A StrathdeeGlobal Health Sciences, Department of Medicine, University of California-San Diego, San Diego, CA, USA.
Nicholas ThomsonCentre for Public Health and Human Rights, Johns Hopkins University, Baltimore, MD, USA; Nossal Institute for Global Health, University of Melbourne, VIC, Australia.
Stefano VellaCenter for Global Health, Istituto Superiore di Sanità, Rome, Italy.
Mauro SchechterDepartment of Preventative Medicine, Universidade Federal do Rio de Janeiro, Rio de Janerio, Brazil.
Peter VickermanSchool of Social and Community Medicine, Bristol Medical School, University of Bristol, Bristol, UK.
Brian WeirDepartment of Health, Behaviour and Society, Johns Hopkins University, Baltimore, MD, USA.
Chris BeyrerInternational AIDS Society, Geneva, Switzerland; Centre for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Modeling Structural HIV Determinants in Substance Users and related populationsR01DA037773 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARTIN, NATASHA, STRATHDEE, STEFFANIE A. · 2015 to 2017
$1.4M
MODELING THE IMPACT OF A POLICE EDUCATION PROGRAM ON HIV INCIDENCE AMONG PEOPLE WHO INJECT DRUGSK01DA043421 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CEPEDA, JAVIER · 2017 to 2021
$941k
Medical Research Council MC_PC_16096NIAID NIH HHS P30 AI036214NIAID NIH HHS P30 AI094189NIDA NIH HHS K01 DA043421NIDA NIH HHS R01 DA037773World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-HIV AgentsFemaleGlobal HealthHealthy People ProgramsHIV InfectionsHumansInternational CooperationMaleSocieties, MedicalAnti-HIV Agents

Identifiers

PMID30032975
PMCPMC6323648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.